CFTR and cystic fibrosis: In Russia and Belarus, neonatal screening for CFTR mutations is performed only when clinical signs of CF or elevated levels of immunoreactive trypsinogen and a positive sweat test are detected; however, an increasing number of regions are also conducting molecular genetic testing for the most common pathogenic CFTR mutations.